Rivastigmine 24HR Patches

Awarded Award Notice Posted

Solicitation number
SPE2D221R0113
Agency
Medical Supply Chain Troop Support, Department of Defense
Awarded
to Mylan Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D222D0147 Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
Saint Albans, Vermont 05478, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical awarded a contract for the provision of Rivastigmine 24HR Patches to Mylan Pharmaceuticals Inc. on September 14, 2022. The initial contract value was $10,967,220.00, with subsequent modifications exercising option periods and increasing the unit price to $38.04 during the second option period from September 14, 2024 to September 13, 2025. The contract also includes a clause prohibiting the contractor from providing any covered articles or products/services from sources prohibited under the Federal Acquisition Supply Chain Security Act.

Notice text

4 versions

Update #4 · Latest ·

Modification SPE2D222D0147 P00005 to Invoke Option Year 2 for the period of September 14, 2024 through September 13, 2025. 

Modification SPE2D222D0147 P00004 to Invoke THIS CONTRACT IS MODIFIED TO INCLUDE 52.204-30 Federal Acquisition Supply Chain Security Act Orders. 

Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024. 

Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract. 

Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract.

Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.

Update #3 ·

Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024. 

Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract. 

Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract.

Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.

Update #2 ·

Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract. 

Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract.

Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.

Update #1 ·

Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

Awarded contract SPE2D222D0147 to Mylan Pharmaceuticals Inc. for 10967220.00 on 2022-09-14.

Attachments

Files attached to this notice, newest first
File Type Posted
SF30_SPE2D222D0147P00004.PDF.pdf PDF
SF30_SPE2D222D0147P00005signed.PDF PDF
SPE2D222D0147 P00003 Option Year 1 mod.PDF PDF
SF30_SPE2D222D0147P00001.PDF PDF
Signed P00002 SPE2D2-22-D-0147.pdf PDF
Signed Rivastigmine 24HR Patch Award SPE2D2-22-D-0147.pdf PDF

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Rivastigmine 24HR Patches This notice · Award Award Notice
Rivastigmine 24HR Patches Latest solicitation Solicitation
Rivastigmine 24HR Patches Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity